Sanofi-aventis Forms Covalent Drug Discovery Partnership with Avila Therapeutics in Oncology

By Heather Cartwright

PharmaDeals Review: Vol 2011 Issue 1 (Table of Contents)

Published: 14 Jan-2011

DOI: 10.3833/pdr.v2011.i1.1420     ISSN: 1756-7874

Section: Joint Venture

Fulltext:

Abstract

Sanofi-aventis has signed a global strategic alliance with Avila Therapeutics that is worth more than US$800 M, including US$40 M upfront and as much as US$770 M in milestone payments...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: PharmaDeals Ltd

Bookmarks

Bookmark PharmaDeals through one of these social networks.